37511361|t|Distinct Molecular Signatures of Amyloid-Beta and Tau in Alzheimer's Disease Associated with Down Syndrome.
37511361|a|Limited comparative data exist on the molecular spectrum of amyloid-beta (Abeta) and tau deposition in individuals with Down syndrome (DS) and sporadic Alzheimer's disease (sAD). We assessed Abeta and tau deposition severity in the temporal lobe and cerebellum of ten DS and ten sAD cases. Immunohistochemistry was performed using antibodies against eight different Abeta epitopes (6F/3D, Abeta38, Abeta39, Abeta40, Abeta42, Abeta43, pyroglutamate Abeta at third glutamic acid (AbetaNp3E), phosphorylated- (p-)Abeta at 8th serine (AbetapSer8)), and six different pathological tau epitopes (p-Ser202/Thr205, p-Thr231, p-Ser396, Alz50, MC1, GT38). Findings were evaluated semi-quantitatively and quantitatively using digital pathology. DS cases had significantly higher neocortical parenchymal deposition (Abeta38, Abeta42, and AbetapSer8), and cerebellar parenchymal deposition (Abeta40, Abeta42, AbetaNp3E, and AbetapSer8) than sAD cases. Furthermore, DS cases had a significantly larger mean plaque size (6F/3D, Abeta42, AbetaNp3E) in the temporal lobe, and significantly greater deposition of cerebral and cerebellar Abeta42 than sAD cases in the quantitative analysis. Western blotting corroborated these findings. Regarding tau pathology, DS cases had significantly more severe cerebral tau deposition than sAD cases, especially in the white matter (p-Ser202/Thr205, p-Thr231, Alz50, and MC1). Greater total tau deposition in the white matter (p-Ser202/Thr205, p-Thr231, and Alz50) of DS cases was confirmed by quantitative analysis. Our data suggest that the Abeta and tau molecular signatures in DS are distinct from those in sAD.
37511361	33	45	Amyloid-Beta	Gene	351
37511361	50	53	Tau	Gene	4137
37511361	57	76	Alzheimer's Disease	Disease	MESH:D000544
37511361	93	106	Down Syndrome	Disease	MESH:D004314
37511361	168	180	amyloid-beta	Gene	351
37511361	182	187	Abeta	Gene	351
37511361	193	207	tau deposition	Disease	MESH:C536599
37511361	228	241	Down syndrome	Disease	MESH:D004314
37511361	243	245	DS	Disease	MESH:D004314
37511361	260	279	Alzheimer's disease	Disease	MESH:D000544
37511361	281	284	sAD	Disease	MESH:D000544
37511361	299	304	Abeta	Gene	351
37511361	309	323	tau deposition	Disease	MESH:C536599
37511361	376	378	DS	Disease	MESH:D004314
37511361	387	390	sAD	Disease	MESH:D000544
37511361	474	479	Abeta	Gene	351
37511361	524	531	Abeta42	Gene	351
37511361	542	555	pyroglutamate	Chemical	MESH:D011761
37511361	556	561	Abeta	Gene	351
37511361	618	623	Abeta	Gene	351
37511361	684	687	tau	Gene	4137
37511361	842	844	DS	Disease	MESH:D004314
37511361	921	928	Abeta42	Gene	351
37511361	995	1002	Abeta42	Gene	351
37511361	1036	1039	sAD	Disease	MESH:D000544
37511361	1060	1062	DS	Disease	MESH:D004314
37511361	1121	1128	Abeta42	Gene	351
37511361	1227	1234	Abeta42	Gene	351
37511361	1240	1243	sAD	Disease	MESH:D000544
37511361	1336	1339	tau	Gene	4137
37511361	1351	1353	DS	Disease	MESH:D004314
37511361	1399	1413	tau deposition	Disease	MESH:C536599
37511361	1419	1422	sAD	Disease	MESH:D000544
37511361	1520	1534	tau deposition	Disease	MESH:C536599
37511361	1597	1599	DS	Disease	MESH:D004314
37511361	1672	1677	Abeta	Gene	351
37511361	1682	1685	tau	Gene	4137
37511361	1710	1712	DS	Disease	MESH:D004314
37511361	1740	1743	sAD	Disease	MESH:D000544
37511361	Association	MESH:D004314	351
37511361	Association	MESH:D000544	4137
37511361	Association	MESH:D004314	4137
37511361	Association	MESH:D000544	351

